BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 15123780)

  • 1. Identification of genes differentially expressed in testes containing carcinoma in situ.
    Hoei-Hansen CE; Nielsen JE; Almstrup K; Hansen MA; Skakkebaek NE; Rajpert-DeMeyts E; Leffers H
    Mol Hum Reprod; 2004 Jun; 10(6):423-31. PubMed ID: 15123780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved gene expression signature of testicular carcinoma in situ.
    Almstrup K; Leffers H; Lothe RA; Skakkebaek NE; Sonne SB; Nielsen JE; Rajpert-De Meyts E; Skotheim RI
    Int J Androl; 2007 Aug; 30(4):292-302; discussion 303. PubMed ID: 17488342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of FGFR3 during human testis development and in germ cell-derived tumours of young adults.
    Ewen KA; Olesen IA; Winge SB; Nielsen AR; Nielsen JE; Graem N; Juul A; Rajpert-De Meyts E
    Int J Dev Biol; 2013; 57(2-4):141-51. PubMed ID: 23784824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulation of the mitosis-meiosis switch in testicular carcinoma in situ.
    Jørgensen A; Nielsen JE; Almstrup K; Toft BG; Petersen BL; Rajpert-De Meyts E
    J Pathol; 2013 Mar; 229(4):588-98. PubMed ID: 23303528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stem cell pluripotency factor NANOG is expressed in human fetal gonocytes, testicular carcinoma in situ and germ cell tumours.
    Hoei-Hansen CE; Almstrup K; Nielsen JE; Brask Sonne S; Graem N; Skakkebaek NE; Leffers H; Rajpert-De Meyts E
    Histopathology; 2005 Jul; 47(1):48-56. PubMed ID: 15982323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcription factor AP-2gamma is a developmentally regulated marker of testicular carcinoma in situ and germ cell tumors.
    Hoei-Hansen CE; Nielsen JE; Almstrup K; Sonne SB; Graem N; Skakkebaek NE; Leffers H; Rajpert-De Meyts E
    Clin Cancer Res; 2004 Dec; 10(24):8521-30. PubMed ID: 15623634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide gene expression profiling of testicular carcinoma in situ progression into overt tumours.
    Almstrup K; Hoei-Hansen CE; Nielsen JE; Wirkner U; Ansorge W; Skakkebaek NE; Rajpert-De Meyts E; Leffers H
    Br J Cancer; 2005 May; 92(10):1934-41. PubMed ID: 15856041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDH1 (E-cadherin) in testicular germ cell neoplasia: suppressed translation of mRNA in pre-invasive carcinoma in situ but increased protein levels in advanced tumours.
    Sonne SB; Hoei-Hansen CE; Nielsen JE; Herlihy AS; Andersson AM; Almstrup K; Daugaard G; Skakkebaek NE; Leffers H; Rajpert-De Meyts E
    APMIS; 2006; 114(7-8):549-58. PubMed ID: 16907861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects.
    Rajpert-De Meyts E
    Hum Reprod Update; 2006; 12(3):303-23. PubMed ID: 16540528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal development.
    Skotheim RI; Lind GE; Monni O; Nesland JM; Abeler VM; Fosså SD; Duale N; Brunborg G; Kallioniemi O; Andrews PW; Lothe RA
    Cancer Res; 2005 Jul; 65(13):5588-98. PubMed ID: 15994931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic and gene expression signature of the pre-invasive testicular carcinoma in situ.
    Almstrup K; Ottesen AM; Sonne SB; Hoei-Hansen CE; Leffers H; Rajpert-De Meyts E; Skakkebaek NE
    Cell Tissue Res; 2005 Oct; 322(1):159-65. PubMed ID: 15846514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered expression of ZO-1 and ZO-2 in Sertoli cells and loss of blood-testis barrier integrity in testicular carcinoma in situ.
    Fink C; Weigel R; Hembes T; Lauke-Wettwer H; Kliesch S; Bergmann M; Brehm RH
    Neoplasia; 2006 Dec; 8(12):1019-27. PubMed ID: 17217619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA expression profiling of carcinoma in situ cells of the testis.
    Novotny GW; Belling KC; Bramsen JB; Nielsen JE; Bork-Jensen J; Almstrup K; Sonne SB; Kjems J; Rajpert-De Meyts E; Leffers H
    Endocr Relat Cancer; 2012 Jun; 19(3):365-79. PubMed ID: 22420006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of a novel human testis-specific kinase substrate gene which is downregulated in testicular tumors.
    Scorilas A; Yousef GM; Jung K; Rajpert-De Meyts E; Carsten S; Diamandis EP
    Biochem Biophys Res Commun; 2001 Jul; 285(2):400-8. PubMed ID: 11444856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transition from preinvasive carcinoma in situ to seminoma is accompanied by a reduction of connexin 43 expression in Sertoli cells and germ cells.
    Neoplasia; ; . PubMed ID: 16820096
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.